Literature DB >> 12211136

Amantadine and other antiglutamate agents: management of Parkinson's disease.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12211136     DOI： 10.1002/mds.5557

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  4 in total

1.  Management of punding in Parkinson's disease: an open-label prospective study.

Authors:  A Fasano; L Ricciardi; M Pettorruso; A R Bentivoglio
Journal:  J Neurol       Date:  2010-11-12       Impact factor: 4.849

2.  Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" Episodes.

Authors:  Amnon A Berger; Ariel Winnick; Jonathan Izygon; Binil M Jacob; Jessica S Kaye; Rachel J Kaye; Elisa E Neuchat; Adam M Kaye; Edward S Alpaugh; Elyse M Cornett; Andrew H Han; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-06-28

Review 3.  Glutamate receptors as therapeutic targets for Parkinson's disease.

Authors:  Kari A Johnson; P Jeffrey Conn; Colleen M Niswender
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

4.  Amantadine for adynamic speech: possible benefit for aphasia?

Authors:  Anna M Barrett; Paul J Eslinger
Journal:  Am J Phys Med Rehabil       Date:  2007-08       Impact factor: 2.159
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.